市場調查報告書
商品編碼
1441198
全球切向流過濾市場規模、佔有率、成長分析、按產品、按技術、按應用、按最終用途 - 行業預測,2023-2030 年Global Tangential Flow Filtration Market Size, Share, Growth Analysis, By Product, By Technology, By Application, By End-use - Industry Forecast 2023-2030 |
2022年全球切向流過濾市場規模預估為21億美元,從2023年的23.4億美元成長到2031年的56億美元,預測期間(2024-2031年)複合年成長率為11.53%。
由於對治療糖尿病、癌症和類風濕性關節炎等各種疾病的生物製藥的需求不斷成長,對切向流過濾 (TFF) 技術的需求正在迅速增加。這種不斷成長的需求是推動市場成長的關鍵因素。 TFF 具有多種優勢,包括高性能、可重複性以及公司採用新的 TFF 產品,所有這些都有助於市場擴張。此外,產業投資的增加和積極的政府舉措正在推動生物製藥製造領域的設施擴建以及新工具和技術的研發。 COVID-19疫苗的大規模生產也為大公司創造了新的機會。此外,最終用戶擴大採用一次性 TFF 設備,特別是隨著一次性生物加工設備在 COVID-19 疫苗生產中越來越被接受。例如,頗爾公司投資了 1.14 億美元,以滿足疫苗生產所需的一次性技術不斷成長的需求。此外,TFF 相對於傳統流動過濾的付加優勢,如提高流速、減少產品累積、簡化清洗和簡化過濾器更換,有助於其高利用率和市場成長。 TFF 的連續過濾製程與自動化相結合,可減少處理時間並提高系統彈性和生產率。這些優勢使得 TFF 系統成為生物製藥製造不可或缺的一部分。此外,公司正在擴大市場佔有率並開發創新技術。例如,Repligen Corporation 於 2021 年獲得了 TFDF(切向流深度過濾)過濾器專利,可最大程度地減少滯留量並提供高助焊劑的一次性解決方案。預計此類進步和技術創新將在預測期內推動產業擴張。
Global Tangential Flow Filtration Market size was valued at USD 2.10 Billion in 2022 and is poised to grow from USD 2.34 Billion in 2023 to USD 5.60 Billion by 2031, at a CAGR of 11.53% during the forecast period (2024-2031).
Tangential flow filtration (TFF) technology is experiencing a surge in demand due to the growing need for biopharmaceuticals to address various diseases, including diabetes, cancer, and rheumatoid arthritis. This rising demand is the primary driver of market growth. TFF offers several advantages such as high performance, reproducibility, and the introduction of new TFF products by companies, all contributing to the market's expansion. Moreover, increased industry investments and supportive government initiatives have led to facility expansions and active research and development efforts for new tools and technologies in biopharmaceutical production. The mass production of the COVID-19 vaccine has also created new opportunities for major firms. Additionally, the adoption of single-use TFF equipment by end-users has increased due to the growing acceptance of single-use biological processing equipment, especially in COVID-19 vaccine production. For example, Pall Corporation invested USD 114 million to meet the rising demand for single-use technology required in vaccine production. Furthermore, the added benefits of TFF over traditional flow filtration, such as increased flow rate, reduced product build-up, simplified cleaning, and filter replacement, contribute to its high utilization rate and market growth. The continuous filtering process of TFF, coupled with automation, reduces processing time and enhances system resilience and productivity. These advantages have made TFF systems indispensable in biopharmaceutical production. Additionally, companies are enhancing their market presence and developing innovative technologies. For instance, Repligen Corporation introduced a patent in 2021 for their Tangential Flow Depth Filtering (TFDF) filter, offering a one-use solution with minimal hold-up volume and high flux. Such advancements and innovations are expected to drive industry expansion over the forecast period.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tangential Flow Filtration and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.
Global Tangential Flow Filtration Market Segmental Analysis
The global tangential flow filtration market is segmented on the basis of product, technology, application, end-use, and region. Based on product, the market is segmented into Single-use Tangential Flow Filtration Systems, Reusable Tangential Flow Filtration Systems, Membrane Filters, and Filtration Accessories. In terms of technology, the market is segmented into Ultrafiltration, Microfiltration, Nanofiltration, and Others. Based on Application the market is segmented into Protein Purification, Vaccine and Viral Vectors, Antibody Purification, Raw Material Filtration, Others. Based on End-user the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic Institutes & Research Laboratories. Based on region the global Tangential Flow Filtration Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Drivers of the Global Tangential Flow Filtration Market
The increasing need for biopharmaceuticals like monoclonal antibodies, vaccines, and recombinant proteins serves as a key catalyst for the TFF market. TFF finds extensive application in the biopharmaceutical sector for purifying and concentrating these products.
Restraints in the Global Tangential Flow Filtration Market
Introducing TFF systems can entail considerable initial expenses for equipment, consumables, and infrastructure. Moreover, ongoing operational costs related to maintenance, validation, and cleaning can be substantial. These factors might limit the uptake of TFF, especially among small and medium-sized enterprises operating within constrained budgets.
Market Trends of the Global Tangential Flow Filtration Market
The adoption of single-use TFF systems is on the rise in the market. Single-use TFF provides numerous benefits such as decreased risk of cross-contamination, streamlined cleaning and validation procedures, and enhanced operational adaptability. The convenience and cost-efficiency of single-use systems are fuelling their incorporation across diverse biopharmaceutical manufacturing operations.
The demand for TFF systems with greater capacity and throughput is escalating alongside the rising production volumes of biopharmaceuticals. Market participants are concentrating on creating high-capacity TFF systems capable of managing larger quantities of feedstock, thereby enhancing process efficiency. These systems facilitate increased productivity and scalability, meeting the industry's requirements for large-scale bioprocessing.
Rise of Comprehensive TFF Solutions: Integrated TFF platforms, which amalgamate various functions like TFF, viral clearance, and ultrafiltration, are increasingly becoming popular in the industry. These unified platforms provide streamlined operations, minimized space requirements, and enhanced process oversight. They facilitate smoother and more effective processes, lessening the reliance on separate systems and elevating manufacturing efficiency as a whole.
Embracing Enhanced TFF Membranes and Materials: Industry participants are consistently dedicating resources to research and innovation to advance TFF membrane technologies and create novel materials. The emphasis lies in refining membranes to boost selectivity, flux rates, and resistance to fouling, aiming to optimize TFF procedures. Additionally, exploration of innovative materials and coatings is underway to tackle distinct filtration hurdles and enhance overall operational efficacy.